SOTSU
SUZHOU, CHINA / ACCESSWIRE / January 23, 2024 / Suzhou Pinyu Precision Mechanical Co., Ltd., parent company of SOTSU, welcomed Michael Locher-Tjoa, COO of SAP Greater China on January 11, 2024. Mr. Locher-Tjoa met with Pinyu and SOTSU CEO Jerry Ruxun Dong while also touring Pinyu and SOTSU's manufacturing, design, engineering, assembly and operation facilities. Jerry introduced Pinyu and SOTSU's vision to Michael: "We create innovative products that help people travel lighter, move faster and learn easier. We want to build 'Made-in-China' into 'Designed-in-China' and 'Innovated-in-China.'"
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.Pinyu recently launched SOTSU, the maker of SOTSU Portable FlipAction Monitor 16, the world's first even-bezel portable monitor, a premium portable monitor that is made with aerospace grade aluminum parts with a 270-degree pivot, comes with a SD slot and a detachable base stand along with two-way passthrough daisy chain charging capabilities. SOTSU is also the creator of SOTSU First Edition Trading Card Game (TCG), the world's first popular manufacturing business TCG which combines real world manufacturing and business concepts creating a one-of-a-kind TCG, collector's item and an educational tool.
"We do not stop at good enough, we benchmark ourselves against the very best in the world because we control the entire product cycle, from a blank piece of paper to scaled production and final assembly. SAP is the world's best ERP system. As we move forward with our digital transformation, we can count on SAP to be with us every step of the way. Putting it simply, SAP cares about its customers," says Jerry Ruxun Dong.
For additional information, please contact Pr@Pinyu.co
Website: www.pinyu.co; www.sotsu.com
Contact Information
SOTSU Brand
pr@pinyu.co
Related Images
|
SOURCE: Suzhou Pinyu Precision Mechanical Co., Ltd.
To view this piece of content from stats.newswire.com, please give your consent at the top of this page.View the original press release on newswire.com.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
TCL Introduces the TCL T6C-UK Fire TV Series with QLED 4K, HDR PRO, and Freely23.4.2025 07:30:00 CEST | Press release
LONDON, UNITED KINGDOM / ACCESS Newswire / April 23, 2025 / TCL, the leading consumer electronics brand and the world's second-largest TV brand as well as an official sponsor of the Olympic Games, is proud to announce the launch of its highly anticipated T6C-UK TV series. The new range offers screen sizes from 43" to 85", ensuring there is a perfect option for every home. Featuring QLED technology, 4K resolution, and an intuitive Fire TV experience, the T6C-UK series offers exceptional picture quality, seamless content access, and smart functionality. The TCL T6C-UK series comes Freely-enabled, offering a seamless way to enjoy live and on-demand TV - all in one place and completely free. With Freely built-in, users can access their favourite streaming apps at the click of a button, eliminating the need to switch between platforms. From major channels to must-watch shows, everything is easily accessible from a single, intuitive home screen. Powered by Fire TV, the T6C-UK series also fea
BioNxt Solutions Prepares for Human Bioequivalence Study For MS23.4.2025 03:05:00 CEST | Press release
VANCOUVER, BC / ACCESS Newswire / April 23, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery systems, is pleased to report advanced preparation for its human bioequivalence study for its lead Multiple Sclerosis (MS) treatment. BioNxt's lead product, BNT23001, is a proprietary sublingual thin-film formulation of Cladribine for the treatment of MS. Preclinical studies, as reported in internal research data and third-party evaluations, have demonstrated high absorption rates and bioequivalence compared to existing oral tablet therapies. The Company has purchased Cladribine active pharmaceutical ingredient which is necessary to complete the technology transfer process with Gen-Plus, its European Contract Research and Development Organization (CRDO), in Munich, Germany. Once commenced, the bioequivalence study is relatively short, scheduled for less than 30 days from start to finish. T
Picktan Capital Eyes a Public Listing on the LSE22.4.2025 09:10:00 CEST | Press release
Picktan Capital Explores Strategic Move Toward Public Listing on the London Stock Exchange in 2026. LONDON, UK / ACCESS Newswire / April 22, 2025 / Picktan Capital, the London-headquartered wealth management firm managing over $7 billion in client assets globally, has confirmed it is in active discussions with several major London-based investment banks to explore the possibility of a public listing on the London Stock Exchange (LSE) in 2026. The firm, known for its disciplined investment approach and bespoke wealth solutions, has formally notified its board of directors and shareholders of its intent to pursue a potential IPO. A strategic review process is currently underway to evaluate the most effective path to the public markets. At a recent shareholder meeting, the proposal to move forward with the listing received unanimous approval, highlighting widespread confidence in the company's direction, leadership, and future growth prospects. Founded with a mission to provide tailored,
ToolsGroup Recognized in the 2025 Gartner(R) Magic Quadrant(TM) for Supply Chain Planning Solutions for the Second Consecutive Year22.4.2025 09:00:00 CEST | Press release
As a trusted partner to retailers, distributors, and manufacturers, ToolsGroup drives results in an uncertain world BOSTON, MA / ACCESS Newswire / April 22, 2025 / ToolsGroup, a global leader in supply chain planning and optimization software, is proud to announce that it has been included in the 2025 Gartner Magic Quadrant for Supply Chain Planning Solutions for the second consecutive year. For retailers, distributors, and manufacturers struggling to deliver results amidst uncertainty, ToolsGroup provides a breakthrough approach to supply chain planning that combines statistical modelling, advanced mathematical optimization, and AI. Customers have the power to shape demand and synchronize supply - replacing guesswork with precision. Built on decades of expertise and a unique probabilistic approach, ToolsGroup's Supply Chain Planning capabilities cover everything from S&OP and demand planning to inventory optimization, replenishment, and transport analytics. Powered by AI and real-time
IXOPAY Appoints Rachel Mae as Vice President of Sales to Execute Global Revenue Strategy Amid Accelerating Market Demand22.4.2025 06:00:00 CEST | Press release
Veteran sales leader joins IXOPAY to deepen customer engagement, expand international growth, and drive high-performance revenue strategy. LEHI, UT / ACCESS Newswire / April 22, 2025 / IXOPAY, a leading enterprise payment orchestration platform, today announced the appointment of Rachel Mae as Vice President of Sales. With over 20 years of experience building and leading high-performing sales organizations in software as a service (SaaS), financial technology (FinTech), and payments, Mae joins IXOPAY to scale the company's global revenue operations and expand its enterprise market footprint. Mae brings a proven track record of driving transformational sales strategies, enabling scalable growth, and developing customer-centric go-to-market teams. Her leadership will be instrumental as IXOPAY continues its global expansion and strengthens its position as the trusted partner for enterprises seeking resilience, flexibility, and optimization in their payment ecosystems. "Rachel brings the k
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom